Orum Therapeutics (XKRX:475830) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 27, 2026)


XKRX:475830 Orum Therapeutics Inc XKRX:475830
7 GF Score
Price ₩49,300.00
! 2 Warning Signs
View Full Analysis

What is Orum Therapeutics Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Orum Therapeutics's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

XKRX:475830 vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Orum Therapeutics's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orum Therapeutics Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orum Therapeutics's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Orum Therapeutics's Margin of Safety % (DCF FCF Based) falls into.


XKRX:475830
7GF Score
Orum Therapeutics Inc XKRX:475830
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orum Therapeutics Business Description

Address Munji-ro, 281-25, 2nd floor, Yuseong-gu, Munji-dong, Daejeon, KOR
Orum Therapeutics Inc is a biotechnology company that develops anticancer drugs with the technology to attach novel drug payloads to ADC. It can develop all three components of ADC, which consist of antibodies, payloads, and linkers, in-house. The group pioneering a class of therapeutics intended to expand the universe of druggable targets and to meaningfully improve upon potency and tolerability, thereby improving the therapeutic window of drugs. Its services include the modeling, research, development, and testing of pharmaceuticals and treatments for such diseases for Orum's partners and licensees. The pipeline products are TPD2GSPT1, TPD2PROTAb, and TPS2Cbl-b.
7GF Score

Get the complete analysis for XKRX:475830

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩49,300.00
Price